4Heikinheimo O,Hsiu JG,Gordon K,et al. Endometrial effects of RD486 in primates-antiproliferation despite signs of estrogen action and increased cyclin-B expression[J]. J Steroid Biochem Mol Biol, 1996,59:179-190.
5Cameron ST, Critchley HO, Thong KJ, et al. Effects of daily low dose mifepristone on endometrial maturation and proliferation[J]. Hum Reprod, 1996,11:2518-2526.
6Moguilewsky M, Philibert D. Biochemical profile of RU486. The antiprogestin steoid RU486 in human fertility control[M].New York: Plenum Press, 1995.87-97.
7McDonnell DP, Goldman ME. RU486 exerts antiestrgenic activities through a novel progesterone receptor A form mediated mechanism[J] .J Biol Chem, 1994,269:11945-11949.
8Sasaki H. Aromatase activites of endometrial carcinomas and both basic and clinical analyses of endometrial hyperplasia as a premalignant disease [J]. Nippon Sanka Fujinkai Zasshi,1993,45:763-775.
9Slayden OD,Nayak NR,Burton KA,et al.Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium [J]. J Clin Endocrinol Metab, 2001,86:2668-2679.
10Chwalisz K, Brenner RM, Fuhrmann UU,et al. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium review[J]. Steroids,2000,65:741-751.
8Carbonell JL, Acosta R, Prez Y, et al.Safety and effectiveness of different dosage of mifepristone for the trealment of uterine fibroids: a double-blind randomized clinical al[J]. Int J Womens Health, 2013,19 ( 5 ) : 115-124.
9Esteve JL, Acosta R, Prez Y, et al.Treatment of uterine myoma with 5 or 10mg mifepristone daily during 6 months, post-treatment evolution over 12 months: double-blind randomised clinical trial[J]. Eur J Obstet Gynecol Reprod Biol,2012, 161 ( 2 ) : 202-208.
10Seth S, Singh E, Mathur A S, et aLLow-dose Mifepristone(25 rag) in Treatment of Uterine Myoma in Perimenopausal Women[J].Joumal of South Asian Federation of Menopause Societies, 2013, 1(1): 34-37.
